Paloma Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Paloma Partners’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26,281	Closed	-$82K	–	2335
2017 Q4	$82K	Buy	+26,281	New	+$73.9K	﹤0.01%	1804
2017 Q3	–	Sell	-112,300	Closed	-$287K	–	2537
2017 Q2	$287K	Buy	+112,300	New	+$306K	﹤0.01%	1818
2014 Q3	–	Sell	-30,000	Closed	-$1.27M	–	1360
2014 Q2	$1.27M	Buy	+30,000	New	+$1.1M	0.05%	300

Other funds holding ISEE

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paloma Partners's ISEE Position: Q1 2018 in Review

Paloma Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2018, closing a stake of 26,281 shares — an estimated $82K sold.

Paloma Partners first reported a position in ISEE in Q2 2014 and held it in 3 quarters. The position peaked at $1.27M in Q2 2014. 71 funds tracked by Wall St. Rank hold ISEE as of Q1 2018.

Paloma Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Paloma Partners sold 26,281 IVERIC bio, Inc. Common Stock shares in Q1 2018, an estimated $82K.
Paloma Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
Paloma Partners's IVERIC bio, Inc. Common Stock position peaked at $1.27M in Q2 2014.
71 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2018.

Based on Paloma Partners's 13F filing for Q1 2018, filed 15 May 2018.